Millennium Management’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $43.2M | Sell |
189,027
-73,302
| -28% | -$16.4M | 0.03% | 933 |
|
|
2025
Q4 | $55.9M | Buy |
262,329
+87,726
| +50% | +$18.1M | 0.04% | 741 |
|
|
2025
Q3 | $34.7M | Buy |
174,603
+101,715
| +140% | +$19M | 0.03% | 1144 |
|
|
2025
Q2 | $12.6M | Sell |
72,888
-191,979
| -72% | -$31.3M | 0.01% | 2020 |
|
|
2025
Q1 | $41.3M | Sell |
264,867
-93,277
| -26% | -$13.3M | 0.04% | 904 |
|
|
2024
Q4 | $49.3M | Sell |
358,144
-143,546
| -29% | -$18.9M | 0.04% | 789 |
|
|
2024
Q3 | $74.9M | Buy |
501,690
+28,241
| +6% | +$3.81M | 0.06% | 581 |
|
|
2024
Q2 | $64.6M | Buy |
473,449
+111,389
| +31% | +$15.2M | 0.05% | 646 |
|
|
2024
Q1 | $54.7M | Buy |
362,060
+339,669
| +1,517% | +$48.5M | 0.05% | 772 |
|
|
2023
Q4 | $2.82M | Sell |
22,391
-20,461
| -48% | -$2.04M | ﹤0.01% | 3309 |
|
|
2023
Q3 | $4.01M | Buy |
+42,852
| New | +$4.01M | ﹤0.01% | 2909 |
|
|
2023
Q1 | – | Sell |
-7,524
| Closed | -$919K | – | 6358 |
|
|
2022
Q4 | $919K | Sell |
7,524
-19,009
| -72% | -$2.21M | ﹤0.01% | 4251 |
|
|
2022
Q3 | $2.74M | Sell |
26,533
-38,390
| -59% | -$3.64M | ﹤0.01% | 3461 |
|
|
2022
Q2 | $6.04M | Sell |
64,923
-92,241
| -59% | -$8.69M | 0.01% | 2602 |
|
|
2022
Q1 | $18.4M | Buy |
157,164
+31,568
| +25% | +$3.66M | 0.02% | 1472 |
|
|
2021
Q4 | $16.9M | Sell |
125,596
-58,788
| -32% | -$8.74M | 0.02% | 1603 |
|
|
2021
Q3 | $29.4M | Buy |
184,384
+175,906
| +2,075% | +$24.1M | 0.04% | 996 |
|
|
2021
Q2 | $1.11M | Sell |
8,478
-60,532
| -88% | -$8.07M | ﹤0.01% | 4567 |
|
|
2021
Q1 | $8.89M | Sell |
69,010
-16,981
| -20% | -$2.58M | 0.01% | 1911 |
|
|
2020
Q4 | $14.3M | Sell |
85,991
-35,347
| -29% | -$5.85M | 0.02% | 1349 |
|
|
2020
Q3 | $18.7K | Sell |
121,338
-86,280
| -42% | -$12.4M | 0.04% | 833 |
|
|
2020
Q2 | $30.7M | Sell |
207,618
-62,459
| -23% | -$8.58M | 0.07% | 506 |
|
|
2020
Q1 | $30.4M | Sell |
270,077
-218,685
| -45% | -$28.4M | 0.12% | 295 |
|
|
2019
Q4 | $68M | Sell |
488,762
-521,581
| -52% | -$57.9M | 0.12% | 245 |
|
|
2019
Q3 | $97.3M | Sell |
1,010,343
-106,611
| -10% | -$11.9M | 0.2% | 114 |
|
|
2019
Q2 | $129M | Sell |
1,116,954
-261,355
| -19% | -$31.3M | 0.24% | 84 |
|
|
2019
Q1 | $162M | Buy |
1,378,309
+1,194,634
| +650% | +$105M | 0.29% | 47 |
|
|
2018
Q4 | $11.5M | Sell |
183,675
-32,379
| -15% | -$2.03M | 0.02% | 1040 |
|
|
2018
Q3 | $15.3M | Sell |
216,054
-351,169
| -62% | -$24.2M | 0.02% | 1011 |
|
|
2018
Q2 | $37.7M | Sell |
567,223
-98,504
| -15% | -$6.48M | 0.05% | 536 |
|
|
2018
Q1 | $43.5M | Buy |
665,727
+134,936
| +25% | +$7.58M | 0.06% | 483 |
|
|
2017
Q4 | $21.3M | Buy |
530,791
+18,377
| +4% | +$668K | 0.03% | 868 |
|
|
2017
Q3 | $18.6M | Buy |
512,414
+293,473
| +134% | +$8.42M | 0.03% | 837 |
|
|
2017
Q2 | $6.08M | Buy |
218,941
+80,558
| +58% | +$2.13M | 0.01% | 1371 |
|
|
2017
Q1 | $3.88M | Sell |
138,383
-88,421
| -39% | -$2.23M | 0.01% | 1607 |
|
|
2016
Q4 | $4.59M | Buy |
226,804
+150,582
| +198% | +$3.01M | 0.01% | 1377 |
|
|
2016
Q3 | $1.53M | Buy |
+76,222
| New | +$1.26M | ﹤0.01% | 2068 |
|
|
2015
Q3 | – | Sell |
-21,384
| Closed | -$378K | – | 3439 |
|
|
2015
Q2 | $378K | Sell |
21,384
-31,737
| -60% | -$555K | ﹤0.01% | 2770 |
|
|
2015
Q1 | $922K | Buy |
+53,121
| New | +$966K | ﹤0.01% | 2359 |
|
Other funds holding ASND
RCM
ACA
